161 related articles for article (PubMed ID: 36841465)
1. Inhibition of monoamine oxidase-a increases respiration in isolated mouse cortical mitochondria.
Kalimon OJ; Vekaria HJ; Gerhardt GA; Sullivan PG
Exp Neurol; 2023 May; 363():114356. PubMed ID: 36841465
[TBL] [Abstract][Full Text] [Related]
2. Effect of long-term treatment with selective monoamine oxidase A and B inhibitors on dopamine release from rat striatum in vivo.
Lamensdorf I; Youdim MB; Finberg JP
J Neurochem; 1996 Oct; 67(4):1532-9. PubMed ID: 8858937
[TBL] [Abstract][Full Text] [Related]
3. Monoamine oxidase-A physically interacts with presenilin-1(M146V) in the mouse cortex.
Wei Z; Gabriel GG; Rui L; Cao X; Pennington PR; Chlan-Fourney J; Nazarali AJ; Baker GB; Mousseau DD
J Alzheimers Dis; 2012; 28(2):403-22. PubMed ID: 22045496
[TBL] [Abstract][Full Text] [Related]
4. Species-dependent differences in monoamine oxidase A and B-catalyzed oxidation of various C4 substituted 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridinyl derivatives.
Inoue H; Castagnoli K; Van Der Schyf C; Mabic S; Igarashi K; Castagnoli N
J Pharmacol Exp Ther; 1999 Nov; 291(2):856-64. PubMed ID: 10525109
[TBL] [Abstract][Full Text] [Related]
5. Properties of monoamine oxidase in monkey heart.
Katayama M; Kobayashi S; Oguchi K; Yasuhara H
Jpn J Pharmacol; 1984 Aug; 35(4):425-31. PubMed ID: 6438377
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of monoamine oxidase activity by antidepressants and mood stabilizers.
Fisar Z; Hroudová J; Raboch J
Neuro Endocrinol Lett; 2010; 31(5):645-56. PubMed ID: 21200377
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of MAO-A fails to alter cocaine-induced increases in extracellular dopamine and norepinephrine in rat nucleus accumbens.
Pepper JP; Baumann MH; Ayestas M; Rothman RB
Brain Res Mol Brain Res; 2001 Mar; 87(2):184-9. PubMed ID: 11245920
[TBL] [Abstract][Full Text] [Related]
8. Biochemical characterization of the active site of brain monoamine oxidase.
Youdim MB
Monogr Neural Sci; 1980; 7():176-92. PubMed ID: 6785574
[TBL] [Abstract][Full Text] [Related]
9. Effect of moclobemide on rat brain monoamine oxidase A and B: comparison with harmaline and clorgyline.
Gerardy J
Prog Neuropsychopharmacol Biol Psychiatry; 1994 Jul; 18(4):793-802. PubMed ID: 7938567
[TBL] [Abstract][Full Text] [Related]
10. SR 95191, a selective inhibitor of type A monoamine oxidase with dopaminergic properties. II. Biochemical characterization of monoamine oxidase inhibition.
Kan JP; Steinberg R; Mouget-Goniot C; Worms P; Bizière K
J Pharmacol Exp Ther; 1987 Jan; 240(1):251-8. PubMed ID: 3100771
[TBL] [Abstract][Full Text] [Related]
11. A new type of mitochondrial monoamine oxidase distinct from type-A and type-B.
Kinemuchi H; Sudo M; Yoshino M; Kawaguchi T; Sunami Y; Kamijo K
Life Sci; 1983 Jan; 32(5):517-24. PubMed ID: 6823208
[TBL] [Abstract][Full Text] [Related]
12. [Possible mechanism of selective inhibition of rat liver mitochondrial monoamine oxidase by chlorgiline and deprenyl].
Severina IS
Biokhimiia; 1979 Feb; 44(2):195-207. PubMed ID: 435561
[TBL] [Abstract][Full Text] [Related]
13. [Effect of solubilization by methylethylketone of rat liver mitochondrial monoamine oxidase on inhibition by clorgyline and deprenyl of the enzyme activity].
Severina IS; Klimova GI; Nersisian AA
Biokhimiia; 1981 Nov; 46(11):2043-55. PubMed ID: 6797482
[TBL] [Abstract][Full Text] [Related]
14. Thyroid iodide transport is reduced by administration of monoamine oxidase A inhibitors to rats.
Cabanillas AM; Masini-Repiso AM; Costamagna ME; Pellizas C; Coleoni AH
J Endocrinol; 1994 Nov; 143(2):303-8. PubMed ID: 7829993
[TBL] [Abstract][Full Text] [Related]
15. Ecstasy-induced oxidative stress to adolescent rat brain mitochondria in vivo: influence of monoamine oxidase type A.
Alves E; Summavielle T; Alves CJ; Custódio JB; Fernandes E; de Lourdes Bastos M; Tavares MA; Carvalho F
Addict Biol; 2009 Apr; 14(2):185-93. PubMed ID: 19076925
[TBL] [Abstract][Full Text] [Related]
16. Potentiation of para-hydroxyamphetamine-induced head-twitch response by inhibition of monoamine oxidase type A in the brain.
Tadano T; Satoh S; Satoh N; Kisara K; Arai Y; Kim SK; Kinemuchi H
J Pharmacol Exp Ther; 1989 Jul; 250(1):254-60. PubMed ID: 2501477
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of monoamine oxidase by clorgyline analogues.
O'Brien EM; Tipton KF; Meroni M; Dostert P
J Neural Transm Suppl; 1994; 41():295-305. PubMed ID: 7931241
[TBL] [Abstract][Full Text] [Related]
18. Effects of Novel Tacrine Derivatives on Mitochondrial Energy Metabolism and Monoamine Oxidase Activity-In Vitro Study.
Hroudová J; Nováková T; Korábečný J; Maliňák D; Górecki L; Fišar Z
Mol Neurobiol; 2021 Mar; 58(3):1102-1113. PubMed ID: 33089424
[TBL] [Abstract][Full Text] [Related]
19. On the characteristics of mitochondrial monoamine oxidase in pancreas and adipose tissues from genetically obese mice.
Tong JH; D'Iorio A; Kandaswami C
Can J Biochem; 1979 Mar; 57(3):197-200. PubMed ID: 436004
[TBL] [Abstract][Full Text] [Related]
20. Striatal damage and oxidative stress induced by the mitochondrial toxin malonate are reduced in clorgyline-treated rats and MAO-A deficient mice.
Maragos WF; Young KL; Altman CS; Pocernich CB; Drake J; Butterfield DA; Seif I; Holschneider DP; Chen K; Shih JC
Neurochem Res; 2004 Apr; 29(4):741-6. PubMed ID: 15098936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
